Beijing Beilu Pharmaceutical Hits Day Low of CNY 7.77 Amid Price Pressure

Beijing Beilu Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 9.11% on July 17, 2026. The stock reached an intraday low of CNY 7.77, reflecting a challenging trading session for the small-cap pharmaceutical company. In terms of performance metrics, Beijing Beilu's one-day performance contrasts with the broader market, as the China Shanghai Composite index fell by 3.05% during the same period. Over the past week, the stock has decreased by 5.01%, slightly outperforming the index, which declined by 5.81%. However, on a year-to-date basis, Beijing Beilu has seen a modest decline of 2.02%, compared to the index's 5.16% drop. Despite the recent downturn, the company has reported positive financial indicators, including a notable 24.59% growth in operating profit and a significant increase in net sales, which reached CNY 652.96 million, growing at 21.7%. The company has also maintained a strong operating cash flow, marking its highest at CNY 255.83 million. These metrics suggest that while the stock is facing short-term pressures, the underlying financial health of Beijing Beilu remains robust.